世界の予測遺伝子検査および消費者/ウェルネスゲノミクスの市場規模は、2027年までに34億ドルと予測されており、予測期間中（2021〜2027）のCAGRは13.9％と推定されます。
予測遺伝子検査は、無症候性の患者の疾患のリスクを予測するための手法です。この方法では、デオキシリボ核酸（DNA）の生体遺伝子の変異/修飾を調べます。これにより正確な次世代プラットフォームシーケンシング結果が得られます。それは治療法を探す際の遺伝的状態を調べるのに役立ちます。遺伝子疾患に対する意識の高まり、遺伝子検査キットの直接販売（DTC）の利用可能性、研究開発投資の増加、健康的なライフスタイルなどが、市場の主な推進要因です。
予測遺伝子検査と消費者/ウェルネスの広範な用途、遺伝子疾患に対する意識の向上、Direct-to-Consumer（DTC）への遺伝子検査キットの利用可能性、R＆Dセクターへの多額の投資、健康的な生活の増加傾向が市場を牽引しています。一方で、予測遺伝子検査の高額な価格がこの市場の成長を抑制する可能性があります。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Application
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE
6.1. Overview
6.2. Predictive Testing
6.2.1. Genetic Susceptibility Test
6.2.2. Predictive Diagnostic
6.2.3. Population Screening
6.3. Consumer Genomics
6.4. Wellness Genomics
6.4.1. Nutria Genetic
6.4.2. Skin & Metabolism Genetics
6.4.3. Others
7. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION
7.1. Overview
7.2. Breast & Ovarian Cancer
7.3. Cardiovascular Screening
7.4. Diabetic Screening & Monitoring
7.5. Colon Cancer
7.6. Parkinsonism/Alzheimer’s Disease
7.7. Urologic Screening/Prostate Cancer Screening
7.8. Orthopedic & Musculoskeletal
7.9. Others
8. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE
8.1. Overview
8.2. Proteomic Testing
8.3. Metabolic Testing
8.4. Genomic Testing
9. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Predictive Genetic Testing & Consumer/Wellness Genomics Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Predictive Genetic Testing & Consumer/Wellness Genomics Market
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players
10.8.1. Sales & Operating Income, 2020
10.8.2. Major Players R&D Expenditure. 2020
11. COMPANY PROFILES
11.1. 23andMe, Inc.
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Myriad Genetics, Inc.
11.3. F.Hoffmann-La Roche Ltd.
11.4. Abbott Laboratories
11.5. Genesis Genetics
11.6. Agilent Technologies
11.7. Thermo Fisher Scientific, Inc.
11.8. Bureau Gravimétrique International
11.9. Bio-Rad Laboratories Inc.
11.10. Illumina, Inc.
11.11. Counsyl, Inc.
11.12. ARUP Laboratories
11.13. Others
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SYNOPSIS, 2018-2027
TABLE 2 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET ESTIMATES & FORECAST, 2018-2027 (USD MILLION)
TABLE 3 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 6 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 9 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 10 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 11 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 12 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 13 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 14 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 15 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 1 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 2 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 3 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 4 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 5 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 6 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 7 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 8 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 9 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 10 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 11 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 12 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 13 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 14 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 15 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 16 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 17 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 18 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 19 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 20 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 21 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 22 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 23 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 24 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 25 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 26 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 27 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 28 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 29 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 30 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 31 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 32 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 33 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 34 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 35 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 36 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 37 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 38 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 39 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 40 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 41 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 42 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 43 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 44 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 45 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 46 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 47 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 48 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 49 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 50 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
TABLE 51 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 52 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 53 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2018-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET
FIGURE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020 (%)
FIGURE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 6 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%)
FIGURE 7 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 12 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 13 23ANDME, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 23ANDME, INC.: SWOT ANALYSIS
FIGURE 15 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 MYRIAD GENETICS INC.: SWOT ANALYSIS
FIGURE 17 F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 19 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 21 GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 GENESIS GENETICS: SWOT ANALYSIS
FIGURE 23 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 AGILENT TECHNOLOGIES: SWOT ANALYSIS
FIGURE 25 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 27 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT ANALYSIS
FIGURE 29 BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 BIO-RAD LABORATORIES INC..: SWOT ANALYSIS
FIGURE 31 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ILLUMINA, INC.: SWOT ANALYSIS
FIGURE 33 COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 COUNSYL, INC.: SWOT ANALYSIS
FIGURE 35 ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 ARUP LABORATORIES: SWOT ANALYSIS
